377 filings
Page 10 of 19
6-K
g9slqlwsp7nnvludxej
6 Mar 18
Current report (foreign)
12:00am
6-K
rfi8cv
23 Feb 18
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006
12:00am
SC 13G/A
vu5y8l26h6g
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
o2xjgadzltg10ufw2v
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
rhvs7
14 Feb 18
Beneficial ownership report (amended)
12:00am
SC 13G/A
1q6yg1y7yszpk
14 Feb 18
GW Pharmaceuticals PLC
12:00am
6-K
z1tb6ipjd18fn9b p0
14 Feb 18
Current report (foreign)
12:00am
SC 13G
62absja4uva
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
am6uwly3kar
13 Feb 18
GW Pharmaceuticals PLC
12:00am
6-K
lyamrua
5 Feb 18
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress
12:00am
6-K
j0mgatuzd7lx9clrh
8 Jan 18
Current report (foreign)
12:00am
CT ORDER
qbnf2 7l9b38fhce1k5
21 Dec 17
Confidential treatment order
12:00am
6-K
bzrm250u
12 Dec 17
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
12:00am
6-K
vvin4idf1dze5d9jn5
8 Dec 17
Current report (foreign)
12:00am
424B5
174ge 7pnu
8 Dec 17
Prospectus supplement for primary offering
12:00am
424B5
wlc271hygtgzs7 p17vr
5 Dec 17
Prospectus supplement for primary offering
12:00am
6-K
9z9jwc j4wf54pc7tsd
4 Dec 17
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress
12:00am
6-K
1tzwym r8w
3 Nov 17
Current report (foreign)
12:00am
6-K
r094oyps
1 Nov 17
Current report (foreign)
12:00am